| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 11 Mar 2021 | 4 Nov 2020 | 11 Mar 2021 |
| Utility: NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 11 Mar 2021 | 21 Oct 2020 | 11 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 4 Mar 2021 | 13 Nov 2020 | 4 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 4 Mar 2021 | 13 Nov 2020 | 4 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 4 Mar 2021 | 4 Nov 2020 | 4 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES Filling date: 9 Sep 2025 Issue date: 18 Feb 2021 | 11 Aug 2020 | 18 Feb 2021 |
| Utility: METHODS FOR PEPTIDE MASS SPECTROMETRY FRAGMENTATION PREDICTION Filling date: 9 Sep 2025 Issue date: 11 Feb 2021 | 7 Aug 2020 | 11 Feb 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 4 Feb 2021 | 16 Oct 2020 | 4 Feb 2021 |
| Utility: RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE Filling date: 9 Sep 2025 Issue date: 4 Feb 2021 | 30 Jul 2020 | 4 Feb 2021 |
| Utility: ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A Filling date: 9 Sep 2025 Issue date: 4 Feb 2021 | 30 Jul 2020 | 4 Feb 2021 |
| Utility: ANTI-WT1/HLA-SPECIFIC ANTIBODIES Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 | 13 Oct 2020 | 28 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 | 13 Oct 2020 | 28 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 | 30 Sep 2020 | 28 Jan 2021 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 | 30 Sep 2020 | 28 Jan 2021 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) Filling date: 9 Sep 2025 Issue date: 14 Jan 2021 | 30 Sep 2020 | 14 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 7 Jan 2021 | 26 Jun 2020 | 7 Jan 2021 |
| Utility: METHODS FOR MANUFACTURING T CELLS BY DIRECT SORTING AND COMPOSITIONS THEREOF Filling date: 9 Sep 2025 Issue date: 7 Jan 2021 | 4 Jun 2020 | 7 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 31 Dec 2020 | 11 Sep 2020 | 31 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 31 Dec 2020 | 11 Sep 2020 | 31 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 24 Dec 2020 | 11 Sep 2020 | 24 Dec 2020 |
| Utility: METHOD OF TREATING WITH A PEPTIDE Filling date: 9 Sep 2025 Issue date: 24 Dec 2020 | 10 Sep 2020 | 24 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 24 Dec 2020 | 10 Sep 2020 | 24 Dec 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 24 Dec 2020 | 30 Jun 2020 | 24 Dec 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 17 Dec 2020 | 30 Jun 2020 | 17 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 10 Dec 2020 | 29 Jun 2020 | 10 Dec 2020 |
| Utility: SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES Filling date: 9 Sep 2025 Issue date: 10 Dec 2020 | 4 Jun 2020 | 10 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 3 Dec 2020 | 29 Jun 2020 | 3 Dec 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 19 Nov 2020 | 6 May 2020 | 19 Nov 2020 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS Filling date: 9 Sep 2025 Issue date: 5 Nov 2020 | 3 Jun 2020 | 5 Nov 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 30 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 29 Jun 2020 | 29 Oct 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 26 Jun 2020 | 29 Oct 2020 |
| Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS Filling date: 9 Sep 2025 Issue date: 29 Oct 2020 | 9 Mar 2020 | 29 Oct 2020 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER Filling date: 9 Sep 2025 Issue date: 22 Oct 2020 | 5 Jun 2020 | 22 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 15 Oct 2020 | 30 Jun 2020 | 15 Oct 2020 |
